Next Article in Journal
Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes
Previous Article in Journal
Clinically Usable Interleukin 12 Plasmid without an Antibiotic Resistance Gene: Functionality and Toxicity Study in Murine Melanoma Model
Article Menu
Issue 3 (March) cover image

Export Article

Open AccessReview
Cancers 2018, 10(3), 61; https://doi.org/10.3390/cancers10030061

Teaming Up for Trouble: Cancer Cells, Transforming Growth Factor-β1 Signaling and the Epigenetic Corruption of Stromal Naïve Fibroblasts

1
Department of Clinical Biochemistry and Pharmacology, Ben Gurion University of the Negev, Beersheva 8410500, Israel
2
Faculty of Health Sciences, Ben Gurion University of the Negev, Beersheva 8410500, Israel
3
Institute of Gastroenterology and Hepatology, Soroka University Medical Center, Beersheva 8410100, Israel
4
Pediatrics Department B, Soroka University Medical Center, Beersheva 8410100, Israel
5
International Institute of Anticancer Research, Kapandriti, Athens 19014, Greece
*
Author to whom correspondence should be addressed.
Received: 10 December 2017 / Revised: 28 January 2018 / Accepted: 21 February 2018 / Published: 27 February 2018
  |  
PDF [821 KB, uploaded 28 February 2018]
  |  

Abstract

It is well recognized that cancer cells subvert the phenotype of stromal naïve fibroblasts and instruct the neighboring cells to sustain their growth agenda. The mechanisms underpinning the switch of fibroblasts to cancer-associated fibroblasts (CAFs) are the focus of intense investigation. One of the most significant hallmarks of the biological identity of CAFs is that their tumor-promoting phenotype is stably maintained during in vitro and ex vivo propagation without the continual interaction with the adjacent cancer cells. In this review, we discuss robust evidence showing that the master cytokine Transforming Growth Factor-β1 (TGFβ-1) is a prime mover in reshaping, via epigenetic switches, the phenotype of stromal fibroblasts to a durable state. We also examine, in detail, the pervasive involvement of TGFβ-1 signaling from both cancer cells and CAFs in fostering cancer development, taking colorectal cancer (CRC) as a paradigm of human neoplasia. Finally, we review the stroma-centric anticancer therapeutic approach focused on CAFs—the most abundant cell population of the tumor microenvironment (TME)—as target cells. View Full-Text
Keywords: cancer; tumor microenvironment; transforming growth factor-β; epigenetics; colorectal cancer; cancer-associated fibroblasts cancer; tumor microenvironment; transforming growth factor-β; epigenetics; colorectal cancer; cancer-associated fibroblasts
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Lamprecht, S.; Sigal-Batikoff, I.; Shany, S.; Abu-Freha, N.; Ling, E.; Delinasios, G.J.; Moyal-Atias, K.; Delinasios, J.G.; Fich, A. Teaming Up for Trouble: Cancer Cells, Transforming Growth Factor-β1 Signaling and the Epigenetic Corruption of Stromal Naïve Fibroblasts. Cancers 2018, 10, 61.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top